I certainly hope not but I do think there is a high probability we could see the $1-$1.50 level in the coming months, assuming another dilutive raise occurs...
We need another $50M or so to get through commercialization (mid 2020), and we run out of the $33M cash on hand (as of 9/30) in the middle of Q2 next year, based on current estimates in the most recent MD&A.
I certainly hope we have seen our last dilutive raise, however, I honestly believe there will be one more in January...
Either way, even if we see $1, I still think we see $20+ in 2021. If we end up with a fully diluted share count of 50M shares, $20 would equate to a $1B valuation. Still a long road ahead but each day gets us one step closer. Bring on 2019!
News 
Market Data 
Discover 
